CD4 and neoplasm: In addition, IFNγ production by effector CD4+ T cells facilitates anti-tumor reactivity by blocking neo-vascularization, directly inhibiting tumor cell proliferation and upregulating tumor-expressed MHC molecules that improve CTL recognition [25].